高效液相色谱法测定人血浆中4'-去甲基表鬼臼毒素-9-(4,6-O-亚乙基-β-D-吡喃葡萄糖苷)(VP 16-213) - Suppr

Suppr

超能文献

High-performance liquid chromatography determination of 4'-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene beta-D-glucopyranoside) (VP 16-213) in human plasma.

作者信息

Farina P, Marzillo G, D'Incalci M

出版信息

J Chromatogr. 1981 Jan 2;222(1):141-5. doi: 10.1016/s0378-4347(00)81044-0.

DOI:10.1016/s0378-4347(00)81044-0

PMID:7217322

Abstract

摘要

相似文献

High-performance liquid chromatography determination of 4'-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene beta-D-glucopyranoside) (VP 16-213) in human plasma.高效液相色谱法测定人血浆中4'-去甲基表鬼臼毒素-9-(4,6-O-亚乙基-β-D-吡喃葡萄糖苷)(VP 16-213)

J Chromatogr. 1981 Jan 2;222(1):141-5. doi: 10.1016/s0378-4347(00)81044-0.

Analysis of 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) by high-pressure liquid chromatography.

J Pharm Sci. 1980 Dec;69(12):1440-1. doi: 10.1002/jps.2600691225.

Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detection.采用高效液相色谱荧光检测法分析抗癌药物依托泊苷（VP 16-213）和替尼泊苷（VM 26）。

J Chromatogr. 1981 Jun 12;224(1):168-74. doi: 10.1016/s0378-4347(00)80153-x.

High-performance liquid chromatography of etoposide in plasma and urine.血浆和尿液中依托泊苷的高效液相色谱法

J Chromatogr. 1985 May 3;339(2):419-23. doi: 10.1016/s0378-4347(00)84674-5.

Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4'-demethyl epipodophyllotoxin thenylidene-beta-D-glucoside and 4'-demethyl epipodophyllotoxin ethylidene-beta-D-glucoside, in the L1210 leukemia cell.两种表鬼臼毒素葡萄糖苷（4'-去甲基表鬼臼毒素噻吩亚甲基-β-D-葡萄糖苷和4'-去甲基表鬼臼毒素亚乙基-β-D-葡萄糖苷）在L1210白血病细胞中的摄取与结合比较

Cancer Res. 1978 Aug;38(8):2549-54.

Simultaneous determination of NK611, a novel water-soluble derivative of etoposide, and its metabolite (DeNK611) in dog plasma by column-switching high performance liquid chromatography.通过柱切换高效液相色谱法同时测定新型水溶性依托泊苷衍生物NK611及其代谢物（DeNK611）在犬血浆中的含量。

Biomed Chromatogr. 1993 Mar-Apr;7(2):82-5. doi: 10.1002/bmc.1130070207.

Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography.采用高效液相色谱法分析抗癌药物VP 16 - 213和VM 26及其代谢产物。

J Chromatogr. 1980 May 9;182(2):211-20. doi: 10.1016/s0378-4347(00)81625-4.

High-performance liquid chromatographic determination of etoposide in plasma using electrochemical detection.

J Chromatogr. 1984 Dec 12;336(2):434-7. doi: 10.1016/s0378-4347(00)85173-7.

Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on human leukemic lymphoblasts.表鬼臼毒素4'-去甲基表鬼臼毒素-9-(4,6-O-2-亚乙基-β-D-吡喃葡萄糖苷)和4'-去甲基表鬼臼毒素-9-(4,6-O-2-噻吩亚甲基-β-D-吡喃葡萄糖苷)及其代谢产物对人白血病淋巴母细胞的细胞毒性和细胞动力学比较效应

Cancer Res. 1983 Dec;43(12 Pt 1):5699-706.

In vitro and in vivo metabolism of VP 16-213 in the rat.VP 16 - 213在大鼠体内外的代谢情况。

Eur J Cancer Clin Oncol. 1982 Sep;18(9):885-90. doi: 10.1016/0277-5379(82)90199-7.

引用本文的文献

Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours.依托泊苷脑室内给药治疗转移性脑肿瘤患者的可行性

Br J Cancer. 2001 Jun 1;84(11):1453-9. doi: 10.1054/bjoc.2001.1841.

In vivo etoposide-resistant C6 glioma cell line: significance of altered DNA topoisomerase II activity in multi-drug resistance.体内依托泊苷耐药C6胶质瘤细胞系：DNA拓扑异构酶II活性改变在多药耐药中的意义

J Neurooncol. 1998 Jan;36(1):41-53. doi: 10.1023/a:1005718912236.

Pharmacokinetics of etoposide: correlation of pharmacokinetic parameters with clinical conditions.依托泊苷的药代动力学：药代动力学参数与临床情况的相关性

Cancer Chemother Pharmacol. 1993;31(5):350-6. doi: 10.1007/BF00686147.

Pharmacokinetics of VP16-213 given by different administration methods.不同给药方式下VP16 - 213的药代动力学。

Cancer Chemother Pharmacol. 1982;7(2-3):141-5. doi: 10.1007/BF00254536.

Pharmacokinetics of VP16-213 in Lewis lung carcinoma bearing mice.

Cancer Chemother Pharmacol. 1982;7(2-3):127-31. doi: 10.1007/BF00254534.

A radioimmunoassay for VP16-213 in plasma.

Cancer Chemother Pharmacol. 1982;7(2-3):117-21. doi: 10.1007/BF00254532.

The clinical pharmacology of VM26 and VP16-213. A brief overview.VM26和VP16 - 213的临床药理学。简要概述。

Cancer Chemother Pharmacol. 1982;7(2-3):133-40. doi: 10.1007/BF00254535.

Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma.

Cancer Chemother Pharmacol. 1985;15(1):66-71. doi: 10.1007/BF00257298.

Drug monitoring of etoposide (VP16-213). Correlation of pharmacokinetic parameters to clinical and biochemical data from patients receiving etoposide.依托泊苷（VP16 - 213）的药物监测。接受依托泊苷治疗患者的药代动力学参数与临床及生化数据的相关性。

Cancer Chemother Pharmacol. 1987;20(1):59-66. doi: 10.1007/BF00252961.

The clinical pharmacology of etoposide and teniposide.依托泊苷和替尼泊苷的临床药理学

Clin Pharmacokinet. 1987 Apr;12(4):223-52. doi: 10.2165/00003088-198712040-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验